Literature DB >> 21880965

Xpert MTB/RIF for rapid diagnosis of tuberculous lymphadenitis from fine-needle-aspiration biopsy specimens.

Louis J Ligthelm1, Mark P Nicol, Kim G P Hoek, Rachael Jacobson, Paul D van Helden, Ben J Marais, Robin M Warren, Colleen A Wright.   

Abstract

This study demonstrates the excellent diagnostic accuracy of the Xpert MTB/RIF test in patients with tuberculous lymphadenitis. The test sensitivity and specificity were 96.7% (95% confidence interval [CI], 86.6 to 100%) and 88.9% (95% CI, 69.6 to 100%), respectively, and it correctly identified 6/6 (100%) of the cytology smear-negative/culture-positive cases and 1 of 2 (50%) rifampin-resistant cases.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21880965      PMCID： PMC3209093          DOI： 10.1128/JCM.01310-11

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  12 in total

1.  Mycobacterial autofluorescence in Papanicolaou-stained lymph node aspirates: a glimmer in the dark?

Authors:  Colleen A Wright; Yvonne van Zyl; Steven M Burgess; Lucille Blumberg; Gladwyn Leiman
Journal:  Diagn Cytopathol       Date:  2004-04       Impact factor: 1.582

2.  Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa.

Authors:  Marinus Barnard; Heidi Albert; Gerrit Coetzee; Richard O'Brien; Marlein E Bosman
Journal:  Am J Respir Crit Care Med       Date:  2008-01-17       Impact factor: 21.405

Review 3.  Extrapulmonary tuberculosis: an overview.

Authors:  Marjorie P Golden; Holenarasipur R Vikram
Journal:  Am Fam Physician       Date:  2005-11-01       Impact factor: 3.292

4.  Rapid molecular detection of tuberculosis and rifampin resistance.

Authors:  Catharina C Boehme; Pamela Nabeta; Doris Hillemann; Mark P Nicol; Shubhada Shenai; Fiorella Krapp; Jenny Allen; Rasim Tahirli; Robert Blakemore; Roxana Rustomjee; Ana Milovic; Martin Jones; Sean M O'Brien; David H Persing; Sabine Ruesch-Gerdes; Eduardo Gotuzzo; Camilla Rodrigues; David Alland; Mark D Perkins
Journal:  N Engl J Med       Date:  2010-09-01       Impact factor: 91.245

5.  The spectrum of disease in children treated for tuberculosis in a highly endemic area.

Authors:  B J Marais; R P Gie; H S Schaaf; A C Hesseling; D A Enarson; N Beyers
Journal:  Int J Tuberc Lung Dis       Date:  2006-07       Impact factor: 2.373

6.  Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology.

Authors:  Danica Helb; Martin Jones; Elizabeth Story; Catharina Boehme; Ellen Wallace; Ken Ho; JoAnn Kop; Michelle R Owens; Richard Rodgers; Padmapriya Banada; Hassan Safi; Robert Blakemore; N T Ngoc Lan; Edward C Jones-López; Michael Levi; Michele Burday; Irene Ayakaka; Roy D Mugerwa; Bill McMillan; Emily Winn-Deen; Lee Christel; Peter Dailey; Mark D Perkins; David H Persing; David Alland
Journal:  J Clin Microbiol       Date:  2009-10-28       Impact factor: 5.948

7.  Diagnosing mycobacterial lymphadenitis in children using fine needle aspiration biopsy: cytomorphology, ZN staining and autofluorescence -- making more of less.

Authors:  Colleen A Wright; Mirjam van der Burg; D Geiger; Jeroen G Noordzij; Steven M Burgess; Ben J Marais
Journal:  Diagn Cytopathol       Date:  2008-04       Impact factor: 1.582

8.  Combining fine-needle aspiration biopsy (FNAB) and high-resolution melt analysis to reduce diagnostic delay in Mycobacterial lymphadenitis.

Authors:  Colleen A Wright; Kim G P Hoek; Ben J Marais; Paul van Helden; Rob M Warren
Journal:  Diagn Cytopathol       Date:  2010-07       Impact factor: 1.582

Review 9.  Fine needle aspiration biopsy: an undervalued diagnostic modality in paediatric mycobacterial disease.

Authors:  C A Wright; R M Warren; B J Marais
Journal:  Int J Tuberc Lung Dis       Date:  2009-12       Impact factor: 2.373

10.  Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study.

Authors:  Catharina C Boehme; Mark P Nicol; Pamela Nabeta; Joy S Michael; Eduardo Gotuzzo; Rasim Tahirli; Ma Tarcela Gler; Robert Blakemore; William Worodria; Christen Gray; Laurence Huang; Tatiana Caceres; Rafail Mehdiyev; Lawrence Raymond; Andrew Whitelaw; Kalaiselvan Sagadevan; Heather Alexander; Heidi Albert; Frank Cobelens; Helen Cox; David Alland; Mark D Perkins
Journal:  Lancet       Date:  2011-04-18       Impact factor: 79.321
View more
  35 in total

1.  Transforming TB diagnosis: can patients and control programs afford to wait?

Authors:  Elizabeth A Talbot; Jean W Pape; Lakshmi Sundaram; Catharina C Boehme; Mark D Perkins
Journal:  Am J Trop Med Hyg       Date:  2012-08       Impact factor: 2.345

2.  Diagnosis of extrapulmonary tuberculosis using the Xpert(®) MTB/RIF assay.

Authors:  Stephen D Lawn; Alimuddin I Zumla
Journal:  Expert Rev Anti Infect Ther       Date:  2012-06       Impact factor: 5.091

Review 3.  Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.

Authors:  Karen R Steingart; Ian Schiller; David J Horne; Madhukar Pai; Catharina C Boehme; Nandini Dendukuri
Journal:  Cochrane Database Syst Rev       Date:  2014-01-21

4.  Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults.

Authors:  Mikashmi Kohli; Ian Schiller; Nandini Dendukuri; Mandy Yao; Keertan Dheda; Claudia M Denkinger; Samuel G Schumacher; Karen R Steingart
Journal:  Cochrane Database Syst Rev       Date:  2021-01-15

Review 5.  Xpert® MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance.

Authors:  Mikashmi Kohli; Ian Schiller; Nandini Dendukuri; Keertan Dheda; Claudia M Denkinger; Samuel G Schumacher; Karen R Steingart
Journal:  Cochrane Database Syst Rev       Date:  2018-08-27

Review 6.  Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care test.

Authors:  Stephen D Lawn; Peter Mwaba; Matthew Bates; Amy Piatek; Heather Alexander; Ben J Marais; Luis E Cuevas; Timothy D McHugh; Lynn Zijenah; Nathan Kapata; Ibrahim Abubakar; Ruth McNerney; Michael Hoelscher; Ziad A Memish; Giovanni Battista Migliori; Peter Kim; Markus Maeurer; Marco Schito; Alimuddin Zumla
Journal:  Lancet Infect Dis       Date:  2013-03-24       Impact factor: 25.071

Review 7.  Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.

Authors:  Karen R Steingart; Hojoon Sohn; Ian Schiller; Lorie A Kloda; Catharina C Boehme; Madhukar Pai; Nandini Dendukuri
Journal:  Cochrane Database Syst Rev       Date:  2013-01-31

8.  Performance of Xpert MTB/RIF in the diagnosis of tuberculous mediastinal lymphadenopathy by endobronchial ultrasound.

Authors:  Devesh J Dhasmana; Clare Ross; Clare J Bradley; David W Connell; Peter M George; Aran Singanayagam; Annette Jepson; Clare Craig; Corrina Wright; Philip L Molyneaux; Melissa Wickremasinghe; Ajit Lalvani; Graham S Cooke; Onn Min Kon
Journal:  Ann Am Thorac Soc       Date:  2014-03

9.  Diagnostic accuracy and effectiveness of the Xpert MTB/RIF assay for the diagnosis of HIV-associated lymph node tuberculosis.

Authors:  A Van Rie; L Page-Shipp; K Mellet; L Scott; M Mkhwnazi; E Jong; T Omar; N Beylis; W Stevens; I Sanne; C N Menezes
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-05-10       Impact factor: 3.267

10.  Diagnostic accuracy of Xpert MTB/RIF for extrapulmonary tuberculosis specimens: establishing a laboratory testing algorithm for South Africa.

Authors:  Lesley Erica Scott; Natalie Beylis; Mark Nicol; Gloria Nkuna; Sebaka Molapo; Leigh Berrie; Adriano Duse; Wendy Susan Stevens
Journal:  J Clin Microbiol       Date:  2014-03-12       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.